B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

USP17L5

MOLECULAR TARGET

ubiquitin specific peptidase 17 like family member 5

UniProt: A8MUK1NCBI Gene: 72838611 compounds

USP17L5 (ubiquitin specific peptidase 17 like family member 5) is targeted by 11 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting USP17L5

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1carnosol1.102
2prunetin1.102
3Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
4Quercetin0.691
5alpha-Linolenic Acid0.691
6salvin [Supplementary Concept]0.691
7celastrol0.691
8Dactinomycin0.691
9piceatannol0.691
10Tetracycline0.691
11withaferin0.691

About USP17L5 as a Drug Target

USP17L5 (ubiquitin specific peptidase 17 like family member 5) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 11 compounds with documented USP17L5 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

USP17L5 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.